Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
Niccolò Bolli(University of Milan), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Michael A. Quail(Wellcome Sanger Institute), Peter J. Campbell(Wellcome Sanger Institute), Paul Costeas(Deakin University), Bram Herman(Agilent Technologies (United Kingdom)), Carolyn Grove(The University of Western Australia), Jufang Chi(Center for the Study of Childhood and Adolescence), Ignacio Varela(Wellcome Sanger Institute), Vijitha Sathiaseelan(Wellcome/MRC Cambridge Stem Cell Institute), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Gunes Gundem(Memorial Sloan Kettering Cancer Center), Thomas McKerrell(Wellcome Sanger Institute), J Craig(Addenbrooke's Hospital), Charles Crawley(Addenbrooke's Hospital), Nicla Manes(Wellcome Sanger Institute), N. Park(Wellcome Sanger Institute), Nathalie Conte(European Bioinformatics Institute)
Cited by 55
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k